×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Bausch & Lomb heeds FDA

Published on .

Bausch & Lomb, Rochester, N.Y., said it received a warning letter from the U.S. Food & Drug Administration requesting the company stop making alleged false claims in professional advertising and promotional materials for PureVision soft contact lenses, launched last month. Company President-Chief Operating Officer Carl Sassano said in a statement Bausch & Lomb takes the "matter seriously" and has halted distribution of the materials. The FDA has objected to claims that the lenses provide "a new level of ocular health"; that they are for "continuous wear" and thus differ from "extended wear" lenses; and that "continuous wear" lenses are superior to "extended wear" lenses because of their design.

Copyright May 1999, Crain Communications Inc.

Most Popular
In this article: